Clincosm LogoSign in Get a demo

Leukemia, Lymphocytic, Chronic, B-Cell

Showing 1 - 25 of 55
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma Trial (Ibrutinib, Venetoclax)

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Small Lymphocytic Lymphoma
  • (no location specified)
Jul 19, 2023

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +5 more
  • (no location specified)
Jul 21, 2023

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (JNJ-75348780)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Birmingham, Alabama
  • +43 more
Jan 27, 2023

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin Trial in Worldwide (JNJ-67856633, Ibrutinib)

Active, not recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Lymphoma, Non-Hodgkin
  • Copenhagen, Denmark
  • +9 more
Jan 27, 2023

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (JNJ-64264681)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • New York, New York
  • +15 more
Jan 27, 2023

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-cell Marginal Zone, Lymphoma, Non-Hodgkin Trial in Worldwide (LOXO-338,

Active, not recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +6 more
  • Duarte, California
  • +8 more
Jan 11, 2023

Determination of Blood Tumor Cells

Completed
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Abnormalities Cell Epithelial
    • Zurich, Switzerland
      University Hospital Zurich
    Jan 9, 2023

    Leukemia, Lymphocytic, Chronic, B-Cell Trial in New York (Zanubrutinib Pill, Venetoclax Pill, Obinutuzumab Injection)

    Not yet recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Zanubrutinib Pill
    • +2 more
    • New York, New York
      Weill Cornell Medicine/NewYork-Presberteryian Hospital
    Dec 6, 2022

    Leukemia, Lymphoid, Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell Trial in China (LOXO-305)

    Active, not recruiting
    • Leukemia, Lymphoid
    • +6 more
    • Wuhu, Anhui, China
    • +22 more
    Dec 8, 2022

    Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Small Lymphocytic Trial in United States (JCAR017 (lisocabtagene maraleucel),

    Active, not recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Lymphoma, Small Lymphocytic
    • JCAR017 (lisocabtagene maraleucel)
    • +2 more
    • Birmingham, Alabama
    • +63 more
    Nov 21, 2022

    Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial (ONO-7018)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • (no location specified)
    Aug 23, 2022

    Non-Hodgkin's B-cell Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Leukemia Trial in Worldwide (MT-3724

    Terminated
    Has Results
    • Non-Hodgkin's B-cell Lymphoma
    • +5 more
    • MT-3724 Phase 1
    • MT-3724 Phase 2
    • Tucson, Arizona
    • +40 more
    Jul 18, 2022

    Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Lymphocytic, Small, Lymphoma, Mantle-Cell Trial in Worldwide (Pirtobrutinib)

    Available
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • +4 more
    • Stanford, California
    • +61 more
    Aug 17, 2022

    Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (JNJ-80948543)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Duarte, California
    • +18 more
    Aug 11, 2022

    Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma Trial in Worldwide (BMS-986403, Fludarabine, Cyclophosphamide)

    Recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Lymphoma
    • Birmingham, Alabama
    • +24 more
    Jul 6, 2022

    Leukemia, Lymphocytic, Chronic, B-Cell Trial in Austria (Bendamustine, Alemtuzumab)

    Completed
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Innsbruck, Tirol, Austria
    • +6 more
    Feb 15, 2022

    Leukemia, Lymphocytic, Chronic, B-Cell Trial in Nanjing (JWCAR029 (Relmacabtagene Autoleucel))

    Not yet recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • JWCAR029 (Relmacabtagene Autoleucel)
    • Nanjing, Jiangsu, China
      Jiangsu Province Hospital
    Feb 17, 2022

    Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (Durvalumab, Lenalidomide, Rituximab)

    Active, not recruiting
    Has Results
    • Lymphoma
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Gilbert, Arizona
    • +53 more
    Jan 25, 2022

    Ibrutinib Retention in Chronic Lymphocytic Leukemia Participants

    Completed
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Ancona, Italy
    • +38 more
    Dec 30, 2021

    Leukemia, Lymphocytic, Chronic, B-Cell, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide

    Completed
    Has Results
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • +2 more
    • Tafasitamab
    • +2 more
    • Jacksonville, Florida
    • +16 more
    Dec 10, 2021

    Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (CC-122, Ibrutinib, Obinutuzumab)

    Completed
    Has Results
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • La Jolla, California
    • +23 more
    Aug 20, 2021

    Family Study of Lymphoproliferative Disorders

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +4 more
      • Rochester, Minnesota
        Mayo Clinic
      Aug 30, 2021

      Leukemia, Lymphocytic, Chronic, B-Cell Trial in Bulgaria, Georgia, Poland (Tenalisib)

      Completed
      Has Results
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • Pleven, Bulgaria
      • +5 more
      Jul 22, 2021

      Leukemia, Lymphoma, Large B-Cell, Diffuse, Leukemia, B-cell Trial in Kunming (CD19 CAR-T cells)

      Recruiting
      • Leukemia
      • +4 more
      • CD19 CAR-T cells
      • Kunming, Yunnan, China
        920th Hospital of Joint Logistics Support Force
      Mar 1, 2021

      Leukemia, Lymphoma, Leukemia, B-Cell Trial in Chongqing (CD19 CAR-T cells)

      Recruiting
      • Leukemia
      • +3 more
      • CD19 CAR-T cells
      • Chongqing, Chongqing, China
        Chongqing University Cancer Hospital
      Mar 1, 2021